ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: For example, specific in vitro activity was detected in TCRs isolated from CML patients, directed against the crucial BCR-ABL mutation, resulting from a translocation between chromosome 22 and 9, found in approximately 95% of CML patients [40].